Hatch-Waxman Safe Harbor Checklist

This checklist discusses the applicability of the drug development safe harbor provision of the Hatch-Waxman Act that creates a broad exemption from patent infringement liability for drug-research activities.

Read now »

Related Content

• Biosimilars and the Biologics Price Competition and Innovation Act (BPCIA)
  Understand the litigation process set up by the BPCIA to facilitate resolution of patent disputes between reference product sponsors and biosimilar manufacturers.

• Plaintiff's Interrogatories in Hatch-Waxman Patent Litigation (Brand to Generic)
  Draft interrogatories designed for use by an innovator patent owner as a starting point in preparing interrogatories for service on a generic challenger accused of infringement under the Hatch-Waxman Act.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

• The Practical Guidance Journal Second Edition 2023 includes legal developments on generative AI, bank failure impacts, and the risks created by crypto-assets.
• Legal Developments provide the latest updates and analyses of emerging topics impacting your practice area. Visit the Legal Developments page to see the latest topics, which also include breaking legal news and related Practical Guidance content. 
• Listen Up! The Practical Guidance and Law360 Podcasts Resource Kit features interviews with industry-leading attorneys on cutting edge issues in the law: NFTs, Cannabis, COVID-19, and more.
• Check out the new Practical Guidance Author Center! Learn about the 1750+ leading attorney authors contributing to our 23 practice areas and find out how you can Become a Practical Guidance Author.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+